Health Care Equipment

Precision Optics

Precision Optics released FY2026 Q3 earnings on May 13 After-Market EST, with actual revenue of USD 8.709 M and EPS of USD -0.0138

Precision Optics released FY2026 9 Months Earnings on May 13 After-Market EST, with actual revenue of USD 22.76 M and EPS of USD -0.4569

Precision Optics FY2026 Q3 Earnings Release on May 13 After-Market EST

Precision Optics released FY2026 Semi-Annual earnings on February 17, 2026, after-market EST, with actual revenue of USD 14.05 M and EPS of USD -0.443

Precision Optics released FY2026 Q2 earnings on February 17 After-Market (EST), actual revenue USD 7.368 M, actual EPS USD -0.2308

Precision Optics FY2026 Q2 Earnings Release on February 17, 2026 After-Market EST

Precision Optics released FY2026 Q1 earnings on November 13 After-Market (EST), actual revenue USD 6.681M, actual EPS USD -0.2121

Precision Optics to Release FY2026 Q1 Earnings Report on November 13, After-Market EST

Precision Optics released FY2025 Annual Earnings on September 29 After-Market (EST), Actual Revenue: USD 19.09 M, Actual EPS: USD -0.8512

Precision Optics released FY2025 Q4 earnings on September 29 After-Market EST, actual revenue USD 6.181 M, actual EPS USD -0.1823

Precision Optics to Release FY2025 Q4 Earnings on September 29 After-Market EST

Precision Optics Corporation to Attend Lytham Partners Spring Investor Conference

Precision Optics Annual General Meeting Elects Directors and Approves Executive Compensation Vote

Precision Optics released FY2025 9 Months Earnings on May 15 After-Market EST, Actual Revenue USD 12.91 M, Actual EPS USD -0.6667

Precision Optics released FY2025 Q3 earnings on May 15 After-Market EST, actual revenue USD 4.186 M, actual EPS USD -0.3031

Precision Optics to Release FY2025 Q3 Earnings on May 15 After-Market EST

Precision Optics Signs Procurement Agreement with Aerospace Customer, Ensuring Minimum Annual Purchase of $4 Million by 2026

Precision Optics released FY2025 Semi-Annual Earnings on February 13 After-Market (EST), with actual revenue of 8.724 M USD and EPS of -0.363 USD

Precision Optics released FY2025 Q2 earnings on February 13 After-Market (EST), actual revenue 4.527 M USD, actual EPS -0.1526 USD

Precision Optics to Release FY2025 Q2 Earnings on February 13 After-Market (EST)

InMed Pharmaceuticals

AMPLITECH GROUP INC. USD0.001 S/R 20/11/26 SER B

Amesite

CN Energy

AMPLITECH GROUP INC. COM USD0.001 (S/R 18/07/2026)

NextNRG

Meiwu Tech

Generation Income Properties

MetaVia

OceanPal

POCI

Precision Optics Corporation (Nasdaq: POCI) will participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026. The company will host a webcast presentation at 1:00 p.m. ET and conduct one-on-one meetings with investors. Founded in 1982, Precision Optics specializes in advanced optical instruments for medical and defense/aerospace industries.

StockTitan

Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 | POCI Stock News

Precision Optics Corporation (POCI) shares surged 23.69% to $5.69 in after-hours trading following a record third-quarter revenue of $8.7 million, more than double last year's $4.2 million. Gross margins improved to 23.6%, and adjusted EBITDA turned positive at $0.3 million. The company raised its FY2026 revenue guidance to $29 million–$31 million, indicating up to 62% growth over FY2025. POCI's market cap is $48.35 million, with a 52-week high of $6.04 and a low of $3.55. Despite the surge, the stock has a negative price trend across all time frames.

Fidelity

Snail

Precision Optics Corporation (POCI) Stock Surges Over 23% Overnight: Why Is It Moving?

AQST

STAA

In Wednesday's after-market session, Staar Surgical (STAA) shares surged 15.3% to $33.9 following Q1 earnings, while Precision Optics (POCI) rose 15.21% to $5.3 after its Q3 report. Other gainers included Aquestive Therapeutics (AQST) up 13.55% to $4.69, and Psyence Biomedical (PBM) up 10.27% to $5.69. Conversely, MDxHealth (MDXH) plummeted 49.2% to $0.99 after its Q1 report, and Doximity (DOCS) fell 17.49% to $19.3 following Q4 earnings. Other notable losers included Sunshine Biopharma (SBFM) and DarioHealth (DRIO).

benzinga_article

Aquestive Therapeutic

STAAR Surgical

Psyence Biomedical

iShares US Pharma

VanEck Biotech ETF

iShares Global Healthcare

Health Care Select Sector SPDR

Invesco Biotechnology & Genome ETF

First Trust Nasdaq Lux Digital Health Solutions ETF

iShares US Healthcare Providers

SPDR S&P Health Equip

ALPS Medical Breakthrough

SPDR S&P Health

First Trust NYSE Arca Biotech Index Fd

Ark Genomic Revolution ETF

Global X HealthTech ETF

Proshares Ultra Nasdaq Biotech

VG Health

Direxion S&P Biotech Bull 3X

iShares US Medical Devices

iShares Biotechnology ETF

PMV Pharma

Quantum Cyber NV

MDxHealth SA

Doximity

Sunshine Biopharma

DarioHealth

Cuprina

Gelteq

PSYENCE BIOMEDICAL LTD C/WTS 25/01/2029(TO PUR COM)

Mainz Biomed NV

SUNSHINE BIOPHARMA INC C/WTS (TO PUR COM)

12 Health Care Stocks Moving In Wednesday's After-Market Session

Precision Optics shares are trading higher after the company reported a year-over-year increase in Q3 financial results.

Precision Optics(POCI.US)

Precision Optics to Participate in the Lytham Partners Spring 2026 Investor Conference on May 28, 2026 | POCI Stock News

Precision Optics Corporation (POCI) Stock Surges Over 23% Overnight: Why Is It Moving?

12 Health Care Stocks Moving In Wednesday's After-Market Session

Precision Optics shares are trading higher after the company reported a year-over-year increase in Q3 financial results.